唾液酸结合免疫球蛋白型凝集素-9 在恶性肿瘤发生发展中的作用研究进展
Research progress on the role of Siglec-9 in the occurrence and development of malignant tumors
唾液酸结合免疫球蛋白型凝集素(Siglec)家族是一类能够识别唾液酸化聚糖结构的膜蛋白,在巨噬细胞、自然杀伤(NK)细胞和 T 细胞等多种免疫细胞上高表达。近年来,随着对 Siglec 调节肿瘤微环境研究的逐步深入,该家族已成为抗肿瘤药物研发的一个重要方向。Siglec-9 是 Siglec 家族成员之一,属于免疫抑制性唾液酸结合受体。在肿瘤微环境、自身免疫性疾病及感染性疾病中,其在免疫细胞膜表面的表达显著增高。Siglec-9 通过与相应配体结合,调控肿瘤生长和炎症反应,这一特性使其成为抗肿瘤治疗的潜在靶点。
The sialic acid-binding immunoglobulin-type lectin (Siglec) family comprises membrane proteins that recognize sialylated glycan structures and is highly expressed on innate immune cells such as macrophages, natural killer (NK) cells, and T cells. In recent years, with increasing research on the role of Siglecs in modulating the tumor microenvironment, they have emerged as important targets for anti-tumor drug development. Siglec-9, a member of the Siglec family, is an immuno-suppressive sialic acid-binding receptor. Its expression is significantly upregulated on immune cells in the tumor micro-environment, as well as in autoimmune and infectious diseases. By binding to its corresponding ligands, Siglec-9 regulates tumor growth and inflammatory responses, making it a potential target for tumor-targeted therapy. This review summarizes the role of Siglec-9 in the development of malignant tumors, aiming to provide new insights and strategies for tumor immun-otherapy.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
Wieboldt R, Sandholzer M, Carlini E, |
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
Xiao H, Woods EC, |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
Toussaint K, Appert-Collin A, Morjani H, |
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
陈启航, 魏湲颜, 江建海. Siglecs 介导肿瘤免疫逃逸的研究进展[J]. 生命的化学, 2021, 41(4): 756-761. DOI: 10.13488/j.smhx.20200587. |
| [56] |
|
| [57] |
|
四川省科技计划项目(2023YFS0488)
/
| 〈 |
|
〉 |